Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Surgical Options for Cushing's Disease

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Medically Reviewed by

Cushing's disease is a rare subtype of Cushing’s syndrome caused by a benign (noncancerous and slow-growing) pituitary tumor that overproduces adrenocorticotropic hormone (ACTH), leading to excessive cortisol production by the adrenal glands. This condition disrupts normal cortisol rhythms and can cause serious complications and early death if left untreated.Β 

Treatment for Cushing’s disease usually involves surgical removal of the adrenal gland, a transsphenoidal adenomectomy, to remove the pituitary tumor.

Surgery is often the primary (first-line) treatment for Cushing's Disease because it directly addresses the root cause of the conditionβ€”a pituitary tumor that secretes excess adrenocorticotropic hormone (ACTH). This minimally invasive procedure has a high success rate in experienced hands.

This article describes the surgical options available for treating Cushing's Disease, including a discussion of their benefits, risks, and outcomes to empower patients and practitioners with what to expect on the healing journey from Cushing’s disease.

[signup]

Understanding the Need for Surgery for Cushing's Disease

Patients diagnosed with Cushing’s disease are often offered surgery as a primary treatment. The goal of therapy is to normalize cortisol levels as soon as possible, and surgery to remove the ACTH-secreting tumor.Β 

The Role of Surgery in Cushing's Disease

Surgery is often required in Cushing's disease to remove the pituitary tumor that is causing excess cortisol production. Surgical removal of the tumor can effectively reduce the overproduction of adrenocorticotropic hormone (ACTH), which normalizes cortisol levels.Β 

Transsphenoidal surgical removal of the pituitary tumor is considered a first-line approach for Cushing’s disease treatment in children and adults because it targets the root cause of the condition, making it the most definitive treatment for achieving long-term remission.

Surgery is most effective when performed by an experienced surgeon. Successful resection can lead to remission in a significant proportion of patients.Β 

When Surgery is Recommended

Surgery is recommended once a diagnosis of Cushing's disease has been confirmed through laboratory testing and the tumor has been located using imaging techniques.

MRI imaging is used to detect pituitary adenomas, especially microadenomas (a tumor less than 10 mm). When the diagnosis is confirmed, and the tumor localized, surgery offers the best chance of curing the disease and normalizing cortisol levels, which alleviates symptoms and reduces the risk of the severe complications associated with Cushing's disease.

Severe complications of Cushing’s disease include cardiovascular issues; metabolic complications including type 2 diabetes mellitus and dyslipidemia; osteoporosis and increased fracture risk; higher risk of infections; mental health issues; increased risk of blood clots; and muscle weakness.

The decision to proceed with surgery on the patient’s overall health and their ability to undergo the procedure. Surgery is most effective when the tumor is small, non-invasive, and clearly identifiable, as this increases the chances of a successful outcome.

Goals of Surgical Treatment

The primary goals of surgical treatment in Cushing's disease are to normalize cortisol levels and reduce the wide range of symptoms caused by hypercortisolism, such as weight gain, high blood pressure, and mood disturbances.Β 

By reducing cortisol to normal levels, surgery also prevents serious complications, including cardiovascular disease, osteoporosis, and diabetes, thereby improving the patient's overall quality of life and long-term health outcomes.

Surgical Options for Cushing's Disease

The primary surgical option for Cushing’s disease is direct removal of the ACTH-secreting pituitary adenoma. When this is not possible, alternate procedures may be considered.

Transsphenoidal Surgery

During transsphenoidal surgery, the nasal passage is used to access and remove pituitary tumors. It is a minimally invasive approach that avoids the need for a craniotomy (a craniotomy is a surgical procedure that involves temporarily removing a portion of the skull to access the brain).

The procedure includes tumor removal, with care taken to avoid damage to surrounding structures, and is followed by reconstruction of the surgical site to prevent complications like cerebrospinal fluid leaks.Β 

This procedure is best suited for patients with small, noninvasive pituitary adenomas causing Cushing’s Disease that are clearly visible on MRI.Β 

Success Rates and Outcomes

Transsphenoidal adenectomy has high success rates, especially when performed by experienced surgeons.Β Β 

After surgery, a patient’s hypothalamic-pituitary-adrenal (HPA) axis may need time to normalize. Successful surgery is indicated by postoperative serum cortisol levels dropping below 55 nmol/L (2 ΞΌg/dL). Patients who achieve remission often require glucocorticoid (GC) replacement until their HPA axis recovers.

However, postsurgical hypocortisolism is considered a good sign. Patients with postsurgical hypocortisolism followed by full adrenal recovery have a very low risk of recurrence. However, those without this complete recovery, especially if their circadian rhythm remains abnormal, are at a higher risk of recurrence.Β 

Immediate post-surgical symptom relief is often observed as hypercortisolism typically resolves quickly. However, long-term symptom relief depends on the person returning to healthy (normal) cortisol levels.

Remission and recurrence rates can vary depending on multiple factors including tumor size, resectability, and the clinical picture of Cushing’s disease. Median rates of remission are given by one source as 77.9%, and median recurrence rates as 11.5%.

Risks and Complications

There are risks associated with surgery, including hypopituitarism and potential complications such as electrolyte disturbances and meningitis from infection. Cerebrospinal fluid (CSF) leaks have also been known to occur.

Potential post-surgical hormonal deficiencies require hormone replacement, so postoperative hormone levels should be monitored.Β 

Postoperative management includes close monitoring for CSF leakage, infection, and monitoring of cortisol levels to assess remission and detect any potential recurrence.

In cases where surgery is not curative or feasible, guidelines suggest considering second-line treatments such as repeat surgery, radiation therapy, or medical therapy.

Adrenalectomy

Adrenalectomy involves the surgical removal of one or both adrenal glands, typically performed through either laparoscopic (minimally invasive) or open surgery. Laparoscopic surgery is the gold standard for adrenal gland removal, which is less invasive and has a faster recovery time than open surgery.

Adrenalectomy is recommended for patients with adrenal tumors or adrenal hyperplasia (an increase in normal, noncancerous cells of the adrenal cortex, causing increased hormone production and adrenal enlargement). Both of these conditions can cause Cushing’s syndrome, leading to excessive cortisol production.Β 

Success Rates and Outcomes

Adrenalectomy is effective in normalizing cortisol levels. However, if the patient undergoes bilateral adrenalectomy (both adrenal glands are removed), the patient will require lifelong hormone replacement therapy, including glucocortiocoids and mineralocorticoids.

Risks and Complications

The risks of laparoscopic adrenalectomy include potential injuries to the liver, spleen, pancreas, duodenum, and inferior vena cava. Liver injuries can occur during retraction, and vena cava trauma might cause severe bleeding, sometimes requiring conversion to open surgery.Β 

Other possible complications are pleural injuries and pneumothorax.

The risks of open adrenalectomy include surgical site infections, which were the most common complication, followed by pulmonary issues like atelectasis and pneumonia. Other significant complications can include deep venous thrombosis, retroperitoneal hematoma, and sepsis.Β 

Nelson Syndrome is a condition that can develop after bilateral adrenalectomy for Cushing's disease. It is characterized by the growth of a residual pituitary adenoma, elevated adrenocorticotropic hormone (ACTH) levels, often exceeding 300 pg/mL, and hyperpigmentation (darkening) of the skin due to increased ACTH production.

After surgery, careful hormone management and monitoring are needed to avoid complications related to adrenal insufficiency. Patients who undergo bilateral adrenalectomy will require close monitoring lifelong.Β 

Ectopic ACTH Tumor Resection

Description of the Procedure

Some tumors called neuroendocrine tumors (NETs), are made up of neuroendocrine cells that make hormones in response to nervous system signals. These tumors constantly release an excessive amount of hormones into the bloodstream.Β 

NETs can develop in various parts of the body, most commonly in the gastrointestinal tract, pancreas, and lungs. They may be benign or malignant and very aggressive.Β 

Some NETs in locations like the pancreas, GI tract, and lungs can secrete ACTH, producing Cushing's syndrome completely independent of the pituitary gland.

Neuroendocrine tumor resection involves surgically removing neuroendocrine tumor completely.Β  This may involve partial removal of surrounding tissues or organs to achieve clear margins (the absence of cancer cells at the outer edge of tissue removed during tumor excision, indicating that the tumor has been completely removed and reducing the risk of recurrence).Β 

NET surgical removal can be minimally invasive (laparoscopic) or open surgery, depending on the tumor's size, location, and involvement of adjacent structures.

Postoperative care involves monitoring for complications like wound infections, bleeding, and abscesses and managing hormone-related symptoms.

Success Rates and Outcomes

Success of the surgery depends on the neuroendocrine tumor location and the feasibility of complete removal. When possible, surgery is considered a cornerstone treatment for NETs, and significant symptom relief is possible if the tumor is fully excised.

Risks and Complications

Risks vary based on tumor location and surgical complexity. Accurate preoperative imaging and meticulous surgical planning are critical for reducing complications.

Pre-Surgical Evaluation and Preparation

Patients can expect a comprehensive evaluation of their condition before the decision to move forward with surgery.

Diagnostic Imaging

Diagnostic imaging including MRI, CT scans, and other technology are commonly used to accurately locate neuroendocrine tumors. These imaging modalities help determine the size, shape, and precise location of the tumor, as well as its relation to surrounding tissues, aiding in effective surgical planning.

Hormonal Assessment

Before surgery, hormonal assessments are conducted to measure cortisol levels and/or other hormones that might be produced by a NET. This helps in understanding the tumor's impact on the patient's endocrine system and guides surgical and postoperative management.

Preparing for Surgery

Preparation involves patient education about the surgical process, potential risks, and realistic expectations for outcomes.Β 

Pre-operative care includes optimizing the patient's health, conducting necessary tests, and planning for post-surgical recovery, ensuring a safer and more effective procedure.

Post-Surgical Care and RecoveryΒ 

Immediately following the surgical procedure, the focus is on monitoring cortisol levels, managing pain, and ensuring early mobilization to reduce the risk of complications such as blood clots or infections.

Other considerations include sodium and thyroid testing. A follow-up MRI is also recommended within 1-3 months of the procedure to determine the new baseline and monitor for recurrence.

Hormone Replacement Therapy

Hypocortisolemic patients should be placed on glucocorticoid replacement after surgery. Regular follow-up with morning cortisol and ACTH stimulation tests helps determine when to safely discontinue glucocorticoid therapy.

Patients who have undergone bilateral adrenalectomy (removal of both adrenal glands) will usually require lifelong steroid replacement therapy to compensate for lost hormone production. Regular follow-ups are necessary to adjust hormone levels and ensure proper management.

Long-Term Monitoring and Follow-Up

Regular check-ups are essential to monitor for tumor recurrence or other complications. Ongoing strategies are needed to manage long-term health and maintain quality of life post-surgery.

Risks, Benefits, and Considerations of Surgery

Any surgical procedure carries risks and the possibility of benefit, which in this setting can be curative. Considerations for a surgical procedure to cure Cushing’s disease include:

Potential Benefits of Surgery

Effective Reduction or Normalization of Cortisol Levels

Surgery is a primary treatment for Cushing’s disease that targets the removal of the ACTH-secreting tumor, which helps normalize cortisol levels and alleviates the symptoms of hypercortisolism.

Potential for Symptom Relief and Improved Quality of Life

Successful surgery can lead to significant symptom relief, including weight loss, reduced blood pressure, improved mood, and lower risks of serious complications like cardiovascular disease, osteoporosis, and diabetes.Β 

This generally results in a better overall quality of life and long-term health outcomes.

Risks and Complications

Detailed Discussion of Risks Specific to Each Surgical Option:

  • Transsphenoidal Surgery: risks include hypopituitarism, electrolyte disturbances, meningitis, cerebrospinal fluid leaks, and potential hormonal deficiencies requiring replacement therapy.
  • Adrenalectomy: potential complications involve injury to nearby organs, risk of infections, bleeding, deep vein thrombosis, and the need for lifelong hormone replacement if both adrenal glands are removed.
  • Ectopic ACTH Tumor Resection: complications depend on tumor location and may include wound infections, bleeding, and hormonal imbalances. Accurate preoperative imaging and careful surgical planning are critical.

Importance of Choosing an Experienced Surgical TeamΒ 

The success of surgical treatment and the reduction of risks significantly depends on the experience and skill of the surgical team. Higher success rates and fewer complications are seen with experienced surgeons.

Making an Informed Decision

Considerations for Patients When Deciding on SurgeryΒ 

Patients should consider the potential benefits of achieving long-term remission and symptom relief against the risks associated with surgical complications and recovery. The patient’s overall health, tumor characteristics, and potential for recurrence should guide the decision-making process.

Importance of Discussing All Options with a Healthcare Provider

Patients should discuss their condition, surgical options, potential risks, and alternatives (such as repeat surgery, radiation, or medical therapy) with their trusted healthcare provider. This allows for a well-informed decision that aligns with the patient's health goals and preferences.

Adjunctive (Post-Operative) Treatments

Medications

Medications, used as alternatives or adjuncts to surgery, focus on controlling cortisol production and alleviating symptoms:

  • Adrenal Steroidogenesis Inhibitors: drugs like ketoconazole, metyrapone, and osilodrostat inhibit enzymes involved in cortisol synthesis. They effectively lower cortisol levels but can cause side effects such as gastrointestinal issues, liver enzyme elevation, and adrenal insufficiency.
  • Somatostatin and Dopamine Receptor Agonists: pasireotide and cabergoline are pituitary-directed treatments that reduce ACTH secretion by targeting pituitary receptors. Pasireotide can normalize urinary cortisol and shrink tumors but may cause hyperglycemia (elevated blood glucose). Cabergoline lowers cortisol and tumor size but can lead to impulse control disorders.
  • Glucocorticoid Receptor Antagonists: mifepristone blocks cortisol action, improving hyperglycemia and weight gain symptoms. It does not lower cortisol levels.

Radiation Therapy

Radiation therapy (RT) is used when surgery is insufficient or tumors are aggressive.Β 

RT can achieve biochemical remission and control tumor growth but often leads to hypopituitarism, requiring lifelong monitoring for tumor recurrence and hormone deficiencies.

Combination Approaches

Combination therapies are often needed for effective control, especially in severe hypercortisolism or when monotherapy fails.Β 

[signup]

Key Takeaways

Summary of Surgical Options:

  • Transsphenoidal Surgery: A minimally invasive procedure through the nasal passage to remove the pituitary tumor, considered the first-line treatment due to its effectiveness in normalizing cortisol levels and achieving long-term remission.
  • Adrenalectomy: Involves the removal of one or both adrenal glands, used when the pituitary surgery is not feasible or fails. This approach effectively reduces cortisol but requires lifelong hormone replacement.
  • Ectopic ACTH Tumor Resection: Targets ACTH-secreting neuroendocrine tumors outside the pituitary gland. Success depends on complete tumor removal, which may require complex surgical planning.

Many patients achieve remission and significant symptom relief following surgery, leading to improved quality of life. It's crucial to seek care from experienced specialists who can provide the most effective treatment and manage potential complications.

Managing Cushing’s Disease effectively requires a team of specialists including endocrinologists, neurosurgeons, and oncologists. A collaborative approach ensures comprehensive care, personalized treatment plans, and better outcomes for patients.

Cushing's disease is a rare subtype of Cushing’s syndrome caused by a benign (noncancerous and slow-growing) pituitary tumor that overproduces adrenocorticotropic hormone (ACTH), leading to excessive cortisol production by the adrenal glands. This condition disrupts normal cortisol rhythms and can cause serious complications if not managed appropriately.Β 

Treatment for Cushing’s disease usually involves surgical removal of the adrenal gland, a transsphenoidal adenomectomy, to remove the pituitary tumor.

Surgery is often the primary (first-line) treatment for Cushing's Disease because it directly addresses the root cause of the conditionβ€”a pituitary tumor that secretes excess adrenocorticotropic hormone (ACTH). This minimally invasive procedure has a high success rate in experienced hands.

This article describes the surgical options available for managing Cushing's Disease, including a discussion of their benefits, risks, and outcomes to empower patients and practitioners with what to expect on the journey to better health from Cushing’s disease.

[signup]

Understanding the Need for Surgery for Cushing's Disease

Patients diagnosed with Cushing’s disease are often offered surgery as a primary treatment. The goal of therapy is to help manage cortisol levels as soon as possible, and surgery to remove the ACTH-secreting tumor.Β 

The Role of Surgery in Cushing's Disease

Surgery is often required in Cushing's disease to remove the pituitary tumor that is causing excess cortisol production. Surgical removal of the tumor can effectively help manage the overproduction of adrenocorticotropic hormone (ACTH), which supports balanced cortisol levels.Β 

Transsphenoidal surgical removal of the pituitary tumor is considered a first-line approach for Cushing’s disease treatment in children and adults because it targets the root cause of the condition, making it the most definitive treatment for achieving long-term remission.

Surgery is most effective when performed by an experienced surgeon. Successful resection can lead to remission in a significant proportion of patients.Β 

When Surgery is Recommended

Surgery is recommended once a diagnosis of Cushing's disease has been confirmed through laboratory testing and the tumor has been located using imaging techniques.

MRI imaging is used to detect pituitary adenomas, especially microadenomas (a tumor less than 10 mm). When the diagnosis is confirmed, and the tumor localized, surgery offers the best chance of managing the disease and supporting balanced cortisol levels, which may help alleviate symptoms and reduce the risk of the severe complications associated with Cushing's disease.

Severe complications of Cushing’s disease include cardiovascular issues; metabolic complications including type 2 diabetes mellitus and dyslipidemia; osteoporosis and increased fracture risk; higher risk of infections; mental health issues; increased risk of blood clots; and muscle weakness.

The decision to proceed with surgery depends on the patient’s overall health and their ability to undergo the procedure. Surgery is most effective when the tumor is small, non-invasive, and clearly identifiable, as this increases the chances of a successful outcome.

Goals of Surgical Treatment

The primary goals of surgical treatment in Cushing's disease are to support balanced cortisol levels and reduce the wide range of symptoms caused by hypercortisolism, such as weight gain, high blood pressure, and mood disturbances.Β 

By supporting balanced cortisol levels, surgery also helps manage serious complications, including cardiovascular disease, osteoporosis, and diabetes, thereby potentially improving the patient's overall quality of life and long-term health outcomes.

Surgical Options for Cushing's Disease

The primary surgical option for Cushing’s disease is direct removal of the ACTH-secreting pituitary adenoma. When this is not possible, alternate procedures may be considered.

Transsphenoidal Surgery

During transsphenoidal surgery, the nasal passage is used to access and remove pituitary tumors. It is a minimally invasive approach that avoids the need for a craniotomy (a craniotomy is a surgical procedure that involves temporarily removing a portion of the skull to access the brain).

The procedure includes tumor removal, with care taken to avoid damage to surrounding structures, and is followed by reconstruction of the surgical site to prevent complications like cerebrospinal fluid leaks.Β 

This procedure is best suited for patients with small, noninvasive pituitary adenomas causing Cushing’s Disease that are clearly visible on MRI.Β 

Success Rates and Outcomes

Transsphenoidal adenectomy has high success rates, especially when performed by experienced surgeons.Β Β 

After surgery, a patient’s hypothalamic-pituitary-adrenal (HPA) axis may need time to normalize. Successful surgery is indicated by postoperative serum cortisol levels dropping below 55 nmol/L (2 ΞΌg/dL). Patients who achieve remission often require glucocorticoid (GC) replacement until their HPA axis recovers.

However, postsurgical hypocortisolism is considered a good sign. Patients with postsurgical hypocortisolism followed by full adrenal recovery have a very low risk of recurrence. However, those without this complete recovery, especially if their circadian rhythm remains abnormal, are at a higher risk of recurrence.Β 

Immediate post-surgical symptom relief is often observed as hypercortisolism typically resolves quickly. However, long-term symptom relief depends on the person returning to healthy (normal) cortisol levels.

Remission and recurrence rates can vary depending on multiple factors including tumor size, resectability, and the clinical picture of Cushing’s disease. Median rates of remission are given by one source as 77.9%, and median recurrence rates as 11.5%.

Risks and Complications

There are risks associated with surgery, including hypopituitarism and potential complications such as electrolyte disturbances and meningitis from infection. Cerebrospinal fluid (CSF) leaks have also been known to occur.

Potential post-surgical hormonal deficiencies require hormone replacement, so postoperative hormone levels should be monitored.Β 

Postoperative management includes close monitoring for CSF leakage, infection, and monitoring of cortisol levels to assess remission and detect any potential recurrence.

In cases where surgery is not curative or feasible, guidelines suggest considering second-line treatments such as repeat surgery, radiation therapy, or medical therapy.

Adrenalectomy

Adrenalectomy involves the surgical removal of one or both adrenal glands, typically performed through either laparoscopic (minimally invasive) or open surgery. Laparoscopic surgery is the gold standard for adrenal gland removal, which is less invasive and has a faster recovery time than open surgery.

Adrenalectomy is recommended for patients with adrenal tumors or adrenal hyperplasia (an increase in normal, noncancerous cells of the adrenal cortex, causing increased hormone production and adrenal enlargement). Both of these conditions can cause Cushing’s syndrome, leading to excessive cortisol production.Β 

Success Rates and Outcomes

Adrenalectomy is effective in supporting balanced cortisol levels. However, if the patient undergoes bilateral adrenalectomy (both adrenal glands are removed), the patient will require lifelong hormone replacement therapy, including glucocortiocoids and mineralocorticoids.

Risks and Complications

The risks of laparoscopic adrenalectomy include potential injuries to the liver, spleen, pancreas, duodenum, and inferior vena cava. Liver injuries can occur during retraction, and vena cava trauma might cause severe bleeding, sometimes requiring conversion to open surgery.Β 

Other possible complications are pleural injuries and pneumothorax.

The risks of open adrenalectomy include surgical site infections, which were the most common complication, followed by pulmonary issues like atelectasis and pneumonia. Other significant complications can include deep venous thrombosis, retroperitoneal hematoma, and sepsis.Β 

Nelson Syndrome is a condition that can develop after bilateral adrenalectomy for Cushing's disease. It is characterized by the growth of a residual pituitary adenoma, elevated adrenocorticotropic hormone (ACTH) levels, often exceeding 300 pg/mL, and hyperpigmentation (darkening) of the skin due to increased ACTH production.

After surgery, careful hormone management and monitoring are needed to avoid complications related to adrenal insufficiency. Patients who undergo bilateral adrenalectomy will require close monitoring lifelong.Β 

Ectopic ACTH Tumor Resection

Description of the Procedure

Some tumors called neuroendocrine tumors (NETs), are made up of neuroendocrine cells that make hormones in response to nervous system signals. These tumors constantly release an excessive amount of hormones into the bloodstream.Β 

NETs can develop in various parts of the body, most commonly in the gastrointestinal tract, pancreas, and lungs. They may be benign or malignant and very aggressive.Β 

Some NETs in locations like the pancreas, GI tract, and lungs can secrete ACTH, producing Cushing's syndrome completely independent of the pituitary gland.

Neuroendocrine tumor resection involves surgically removing neuroendocrine tumor completely.Β  This may involve partial removal of surrounding tissues or organs to achieve clear margins (the absence of cancer cells at the outer edge of tissue removed during tumor excision, indicating that the tumor has been completely removed and reducing the risk of recurrence).Β 

NET surgical removal can be minimally invasive (laparoscopic) or open surgery, depending on the tumor's size, location, and involvement of adjacent structures.

Postoperative care involves monitoring for complications like wound infections, bleeding, and abscesses and managing hormone-related symptoms.

Success Rates and Outcomes

Success of the surgery depends on the neuroendocrine tumor location and the feasibility of complete removal. When possible, surgery is considered a cornerstone treatment for NETs, and significant symptom relief is possible if the tumor is fully excised.

Risks and Complications

Risks vary based on tumor location and surgical complexity. Accurate preoperative imaging and meticulous surgical planning are critical for reducing complications.

Pre-Surgical Evaluation and Preparation

Patients can expect a comprehensive evaluation of their condition before the decision to move forward with surgery.

Diagnostic Imaging

Diagnostic imaging including MRI, CT scans, and other technology are commonly used to accurately locate neuroendocrine tumors. These imaging modalities help determine the size, shape, and precise location of the tumor, as well as its relation to surrounding tissues, aiding in effective surgical planning.

Hormonal Assessment

Before surgery, hormonal assessments are conducted to measure cortisol levels and/or other hormones that might be produced by a NET. This helps in understanding the tumor's impact on the patient's endocrine system and guides surgical and postoperative management.

Preparing for Surgery

Preparation involves patient education about the surgical process, potential risks, and realistic expectations for outcomes.Β 

Pre-operative care includes optimizing the patient's health, conducting necessary tests, and planning for post-surgical recovery, ensuring a safer and more effective procedure.

Post-Surgical Care and RecoveryΒ 

Immediately following the surgical procedure, the focus is on monitoring cortisol levels, managing pain, and ensuring early mobilization to reduce the risk of complications such as blood clots or infections.

Other considerations include sodium and thyroid testing. A follow-up MRI is also recommended within 1-3 months of the procedure to determine the new baseline and monitor for recurrence.

Hormone Replacement Therapy

Hypocortisolemic patients should be placed on glucocorticoid replacement after surgery. Regular follow-up with morning cortisol and ACTH stimulation tests helps determine when to safely discontinue glucocorticoid therapy.

Patients who have undergone bilateral adrenalectomy (removal of both adrenal glands) will usually require lifelong steroid replacement therapy to compensate for lost hormone production. Regular follow-ups are necessary to adjust hormone levels and ensure proper management.

Long-Term Monitoring and Follow-Up

Regular check-ups are essential to monitor for tumor recurrence or other complications. Ongoing strategies are needed to manage long-term health and maintain quality of life post-surgery.

Risks, Benefits, and Considerations of Surgery

Any surgical procedure carries risks and the possibility of benefit, which in this setting can be curative. Considerations for a surgical procedure to manage Cushing’s disease include:

Potential Benefits of Surgery

Effective Reduction or Normalization of Cortisol Levels

Surgery is a primary treatment for Cushing’s disease that targets the removal of the ACTH-secreting tumor, which helps support balanced cortisol levels and may alleviate the symptoms of hypercortisolism.

Potential for Symptom Relief and Improved Quality of Life

Successful surgery can lead to significant symptom relief, including weight loss, reduced blood pressure, improved mood, and lower risks of serious complications like cardiovascular disease, osteoporosis, and diabetes.Β 

This generally results in a better overall quality of life and long-term health outcomes.

Risks and Complications

Detailed Discussion of Risks Specific to Each Surgical Option:

  • Transsphenoidal Surgery: risks include hypopituitarism, electrolyte disturbances, meningitis, cerebrospinal fluid leaks, and potential hormonal deficiencies requiring replacement therapy.
  • Adrenalectomy: potential complications involve injury to nearby organs, risk of infections, bleeding, deep vein thrombosis, and the need for lifelong hormone replacement if both adrenal glands are removed.
  • Ectopic ACTH Tumor Resection: complications depend on tumor location and may include wound infections, bleeding, and hormonal imbalances. Accurate preoperative imaging and careful surgical planning are critical.

Importance of Choosing an Experienced Surgical TeamΒ 

The success of surgical treatment and the reduction of risks significantly depends on the experience and skill of the surgical team. Higher success rates and fewer complications are seen with experienced surgeons.

Making an Informed Decision

Considerations for Patients When Deciding on SurgeryΒ 

Patients should consider the potential benefits of achieving long-term remission and symptom relief against the risks associated with surgical complications and recovery. The patient’s overall health, tumor characteristics, and potential for recurrence should guide the decision-making process.

Importance of Discussing All Options with a Healthcare Provider

Patients should discuss their condition, surgical options, potential risks, and alternatives (such as repeat surgery, radiation, or medical therapy) with their trusted healthcare provider. This allows for a well-informed decision that aligns with the patient's health goals and preferences.

Adjunctive (Post-Operative) Treatments

Medications

Medications, used as alternatives or adjuncts to surgery, focus on controlling cortisol production and alleviating symptoms:

  • Adrenal Steroidogenesis Inhibitors: drugs like ketoconazole, metyrapone, and osilodrostat inhibit enzymes involved in cortisol synthesis. They effectively lower cortisol levels but can cause side effects such as gastrointestinal issues, liver enzyme elevation, and adrenal insufficiency.
  • Somatostatin and Dopamine Receptor Agonists: pasireotide and cabergoline are pituitary-directed treatments that reduce ACTH secretion by targeting pituitary receptors. Pasireotide can normalize urinary cortisol and shrink tumors but may cause hyperglycemia (elevated blood glucose). Cabergoline lowers cortisol and tumor size but can lead to impulse control disorders.
  • Glucocorticoid Receptor Antagonists: mifepristone blocks cortisol action, improving hyperglycemia and weight gain symptoms. It does not lower cortisol levels.

Radiation Therapy

Radiation therapy (RT) is used when surgery is insufficient or tumors are aggressive.Β 

RT can achieve biochemical remission and control tumor growth but often leads to hypopituitarism, requiring lifelong monitoring for tumor recurrence and hormone deficiencies.

Combination Approaches

Combination therapies are often needed for effective control, especially in severe hypercortisolism or when monotherapy fails.Β 

[signup]

Key Takeaways

Summary of Surgical Options:

  • Transsphenoidal Surgery: A minimally invasive procedure through the nasal passage to remove the pituitary tumor, considered the first-line treatment due to its effectiveness in supporting balanced cortisol levels and achieving long-term remission.
  • Adrenalectomy: Involves the removal of one or both adrenal glands, used when the pituitary surgery is not feasible or fails. This approach effectively supports balanced cortisol but requires lifelong hormone replacement.
  • Ectopic ACTH Tumor Resection: Targets ACTH-secreting neuroendocrine tumors outside the pituitary gland. Success depends on complete tumor removal, which may require complex surgical planning.

Many patients achieve remission and significant symptom relief following surgery, leading to improved quality of life. It's crucial to seek care from experienced specialists who can provide the most effective treatment and manage potential complications.

Managing Cushing’s Disease effectively requires a team of specialists including endocrinologists, neurosurgeons, and oncologists. A collaborative approach ensures comprehensive care, personalized treatment plans, and better outcomes for patients.

The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No lab tests!

Al-Kurd, A., Chapchay, K., Grozinsky-Glasberg, S., & Mazeh, H. (2014). Laparoscopic resection of pancreatic neuroendocrine tumors. World journal of gastroenterology, 20(17), 4908–4916. https://doi.org/10.3748/wjg.v20.i17.4908

Bryant, A. (2024, August 5). Understanding Idiopathic Pneumothorax: Risk Factors, Symptoms, and Advanced Treatment Options. Rupa Health. https://www.rupahealth.com/post/idiopathic-pneumothoraxΒ 

Buliman, A., Tataranu, L. G., Paun, D. L., Mirica, A., & Dumitrache, C. (2016). Cushing's disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment. Journal of medicine and life, 9(1), 12–18.

Castinetti, F., Morange, I., Conte-Devolx, B., & Brue, T. (2012). Cushing’s disease. Orphanet Journal of Rare Diseases, 7(1), 41. https://doi.org/10.1186/1750-1172-7-41

Chaudhry HS, Singh G. Cushing Syndrome. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470218/

Chourpiliadis C, Aeddula NR. Physiology, Glucocorticoids. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560897/

Cloyd, J. A Root Cause Medicine Protocol For Patients With Osteoporosis: Testing, Therapeutic Diet, and Supportive Supplements. (2023, September 6). Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-protocol-for-patients-with-osteoporosis-testing-therapeutic-diet-and-supportive-supplements

Cloyd, J. (2024, June 7). Cortisol and Anxiety: Understanding the Connection. Rupa Health. https://www.rupahealth.com/post/cortisol-and-anxietyΒ Β 

Cloyd, J. Cortisol and Weight Gain: Understanding the Connection. (2024, April 15). Rupa Health. https://www.rupahealth.com/post/cortisol-and-weight-gain-understanding-the-connectionΒ 

Cortisol. Rupa Health. https://www.rupahealth.com/biomarkers/cortisolΒ 

DePorto T. Worried About Heart Disease? Ask Your Provider for These 6 Specialty Labs at Your Next Appointment. Rupa Health. Published December 9, 2022. https://www.rupahealth.com/post/worried-about-heart-disease-ask-your-provider-for-these-6-specialty-labs-at-your-next-appointmentΒ 

Diorio, B. (2023, March 17). How to test for hypothalamic-pituitary-adrenal (HPA) axis dysfunction. Rupa Health. https://www.rupahealth.com/post/what-is-the-hypothalamic-pituitary-adrenal-hpa-axis

Estrada, J., GarcΓ­a-UrΓ­a, J., Lamas, C., Alfaro, J., Lucas, T., Diez, S., Salto, L., & BarcelΓ³, B. (2001). The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease. The Journal of clinical endocrinology and metabolism, 86(12), 5695–5699. https://doi.org/10.1210/jcem.86.12.8069

Fariba KA, Gokarakonda SB. Impulse Control Disorders. [Updated 2023 Aug 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562279/Β 

FernΓ‘ndez-de Thomas RJ, Munakomi S, De Jesus O. Craniotomy. [Updated 2023 Aug 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560922/

Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., Casanueva, F. F., Castinetti, F., Chanson, P., Findling, J., Gadelha, M., Geer, E. B., Giustina, A., Grossman, A., Gurnell, M., Ho, K., … Biller, B. M. K. (2021). Consensus on diagnosis and management of Cushing's disease: a guideline update. The lancet. Diabetes & endocrinology, 9(12), 847–875. https://doi.org/10.1016/S2213-8587(21)00235-7

Grott K, Chauhan S, Sanghavi DK, et al. Atelectasis. [Updated 2024 Feb 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545316/

Han, S. Y., Kim, B. H., Jang, H. R., Kim, W. J., Jeon, Y. K., Kim, S. S., & Kim, I. J. (2016). Ectopic ACTH syndrome caused by pulmonary carcinoid tumor mimicking long-standing sclerosing hemangioma. The Korean Journal of Internal Medicine, 31(4), 794–797. https://doi.org/10.3904/kjim.2014.320

Hodgens A, Sharman T. Corticosteroids. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554612/

Isidori, A. M., Kaltsas, G., & Grossman, A. B. (2006). Ectopic ACTH Syndrome. 143–156. https://doi.org/10.1159/000094323

Kairys N, Anastasopoulou C, Schwell A. Cushing Disease. [Updated 2023 Feb 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448184/

Kaltsas, G., Besser, G. M., & Grossman, A. B. (2004). The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors. 25(3), 458–511. https://doi.org/10.1210/er.2003-0014

Kelly D. F. (2007). Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome. Neurosurgical focus, 23(3), E5. https://doi.org/10.3171/foc.2007.23.3.7

Khakham, C. (2023, August 25). Top Labs To Run Bi-Annually On Your High Blood Pressure Patients. Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-high-blood-pressure-patientsΒ 

Maholy N. The Role Of Sleep And Circadian Rhythms In Neurological Health. Rupa Health. Published June 15, 2023. https://www.rupahealth.com/post/the-role-of-sleep-and-circadian-rhythms-in-neurological-healthΒ 

Maione, F., Chini, A., Milone, M., Gennarelli, N., Manigrasso, M., Maione, R., Cassese, G., Pagano, G., Tropeano, F. P., Luglio, G., & De Palma, G. D. (2021). Diagnosis and Management of Rectal Neuroendocrine Tumors (NETs). Diagnostics (Basel, Switzerland), 11(5), 771. https://doi.org/10.3390/diagnostics11050771

Mellon MJ, Sethi A, Sundaram CP. Laparoscopic adrenalectomy: Surgical techniques. Indian Journal of Urology : IJU : Journal of the Urological Society of India. 2008;24(4):583-589. doi:https://doi.org/10.4103/0970-1591.44277

National Heart, Lung and Blood Institute. (2022, March 24). Pneumonia. Www.nhlbi.nih.gov; NIH. https://www.nhlbi.nih.gov/health/pneumoniaΒ 

Nieman L. K. (2018). Recent Updates on the Diagnosis and Management of Cushing's Syndrome. Endocrinology and metabolism (Seoul, Korea), 33(2), 139–146. https://doi.org/10.3803/EnM.2018.33.2.139

Nieman, L. K., Biller, B. M., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., Tabarin, A., & Endocrine Society (2015). Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism, 100(8), 2807–2831. https://doi.org/10.1210/jc.2015-1818

Orbeta, R. (2022, June 6). 10 Type 2 Diabetes Risk Factors You May Not Know About. Rupa Health. https://www.rupahealth.com/post/what-causes-type-2-diabetes

PaleΕ„-Tytko, J. E., Przybylik-Mazurek, E. M., Rzepka, E. J., Pach, D. M., Sowa-Staszczak, A. S., Gilis-Januszewska, A., & Hubalewska-Dydejczyk, A. B. (2020). Ectopic ACTH syndrome of different origin-Diagnostic approach and clinical outcome. Experience of one Clinical Centre. PloS one, 15(11), e0242679. https://doi.org/10.1371/journal.pone.0242679

Pappachan, J. M., Hariman, C., Edavalath, M., Waldron, J., & Hanna, F. W. (2017). Cushing’s syndrome: a practical approach to diagnosis and differential diagnoses. Journal of Clinical Pathology, 70(4), 350–359. https://doi.org/10.1136/jclinpath-2016-203933

Petersenn, S., Beckers, A., Ferone, D., van der Lely, A., Bollerslev, J., Boscaro, M., Brue, T., Bruzzi, P., Casanueva, F. F., Chanson, P., Colao, A., Reincke, M., Stalla, G., & Tsagarakis, S. (2015). Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. European journal of endocrinology, 172(6), R227–R239. https://doi.org/10.1530/EJE-14-0883

Steffensen, C., Bak, A. M., Rubeck, K. Z., & JΓΈrgensen, J. O. (2010). Epidemiology of Cushing's syndrome. Neuroendocrinology, 92 Suppl 1, 1–5. https://doi.org/10.1159/000314297

Sweetnich, J. (2023, June 12). Integrative Treatment Options for Adrenal Disorders: Specialty Testing, Nutrition, Supplements. Rupa Health. https://www.rupahealth.com/post/integrative-treatment-options-for-adrenal-disorders-specialty-testing-nutrition-supplementsΒ 

Sweetnich, J. (2023, March 15). Sodium 101: Lab Tests, Disorders, & How Much To Consume Daily. Rupa Health. https://www.rupahealth.com/post/sodium-101Β 

Telano LN, Baker S. Physiology, Cerebral Spinal Fluid. [Updated 2023 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519007/

Thompson, S. K., Hayman, A. V., Ludlam, W. H., Deveney, C. W., Loriaux, D. L., & Sheppard, B. C. (2007). Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience. Annals of surgery, 245(5), 790–794. https://doi.org/10.1097/01.sla.0000251578.03883.2f

Waheed SM, Kudaravalli P, Hotwagner DT. Deep Vein Thrombosis. [Updated 2023 Jan 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507708/Β 

Weinberg, J. ACTH Hormone: Roles, Regulation, and Health Implications. (2024, April 5). Rupa Health. https://www.rupahealth.com/post/acth-hormone-roles-regulation-and-health-implications

Weinberg J. What is Cushing’s Syndrome?: Testing and Treatments. Rupa Health. Published March 6, 2024. https://www.rupahealth.com/post/what-is-cushings-syndrome-testing-and-treatmentsΒ 

Williams, J. K., Schwarz, J. L., & Keutgen, X. M. (2023). Surgery for metastatic pancreatic neuroendocrine tumors: a narrative review. Hepatobiliary surgery and nutrition, 12(1), 69–83. https://doi.org/10.21037/hbsn-22-238

Xing, B., Zhang, N., Ren, Z. Y., Su, C. B., Wang, R. Z., Yang, Y., Ma, W. B., & Li, Y. N. (2008). Zhonghua wai ke za zhi [Chinese journal of surgery], 46(8), 592–594.

Yoshimura, H. (2023, October 3). Digging Deeper: How Root Cause Medicine Addresses Chronic Health Issues. Rupa Health. https://www.rupahealth.com/post/digging-deeper-how-root-cause-medicine-addresses-chronic-health-issuesΒ 

Zubair A, Das JM. Transsphenoidal Hypophysectomy. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556142/

Zubair, A. B., Arif, M. H., Razzaq, M. T., Zaman, M., Haider, Z., Fajar, I. E., Saleem, S., Khalil, A., Sabir, M., & Kaneez, M. (2022). The Spectrum of Postoperative Complications and Outcomes After Open Adrenalectomy: An Experience From a Developing Country. Cureus, 14(11), e31357. https://doi.org/10.7759/cureus.31357

Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles
Trusted Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
CDC
Government Authority
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
National Institutes of Health
Government Authority
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Brain
Peer Reviewed Journal
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source